Michael S. Wyzga served as President, CEO and Board Member of Radius Health, Inc. from 2011 to 2013. Radius is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.
Prior to joining Radius, Wyzga held multiple senior management roles at Genzyme Corporation, including Chief Financial Officer from 1999 to 2011 and Executive Vice President of Finance from 2003 to 2011.
He currently serves as a Director for pharmaceutical companies Akebia Therapeutics, Inc. and Oncomed Pharmaceuticals, Inc. Wygza received his BS from Suffolk University and his MBA from Providence College.
- Chair of the Audit Committee